Christopher Brooke
Direttore operativo presso SwanBio Therapeutics, Inc.
Patrimonio netto: 165 734 $ in data 30/04/2024
Profilo
Christopher Brooke is the founder of Rumpus Therapeutics.
He is currently the Chief Operating Officer at SwanBio Therapeutics, Inc. where he started in 2023.
Prior to this, he was the Chief Operating Officer at Aytu Biopharma, Inc. from 2021 to 2023.
Mr. Brooke received his undergraduate degree from Colgate University and his MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
AYTU BIOPHARMA, INC.
1.05% | 11/08/2023 | 58 357 ( 1.05% ) | 165 734 $ | 30/04/2024 |
Posizioni attive di Christopher Brooke
| Società | Posizione | Inizio |
|---|---|---|
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Direttore operativo | 16/10/2023 |
Precedenti posizioni note di Christopher Brooke
| Società | Posizione | Fine |
|---|---|---|
| AYTU BIOPHARMA, INC. | Direttore operativo | 13/10/2023 |
| Rumpus Therapeutics | Fondatore | - |
Formazione di Christopher Brooke
| Colgate University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AYTU BIOPHARMA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |
| Rumpus Therapeutics |
- Borsa valori
- Insiders
- Christopher Brooke
